I Mendez Selected Research

Poloxamer (Poloxamer 407)

1/2008

Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

I Mendez Research Topics

Disease

10	Parkinson Disease (Parkinson's Disease) 08/2008 - 04/2000
3	Wounds and Injuries (Trauma) 01/2005 - 03/2000
2	Huntington Disease (Huntington's Disease) 01/2006 - 04/2000
2	Neoplasms (Cancer) 01/2006 - 02/2001
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2005 - 02/2001
1	Tuberculosis (Tuberculoses) 06/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2006
1	Aneurysm (Aneurysms) 08/2000
1	Nervous System Diseases (Neurological Disorders) 04/2000
1	Stroke (Strokes) 04/2000

Drug/Important Bio-Agent (IBA)

3	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 07/2007 - 05/2000
1	AcidsIBA 06/2017
1	Rifampin (Rifampicin)FDA LinkGeneric 06/2017
1	Poloxamer (Poloxamer 407)IBA 01/2008
1	Surface-Active Agents (Surfactants)IBA 01/2008
1	Dopamine (Intropin)FDA LinkGeneric 07/2007
1	Erythropoietin FDA Link 07/2006
1	SuspensionsIBA 01/2006
1	Proteins (Proteins, Gene)FDA Link 01/2005
1	AntioxidantsIBA 01/2005
1	Glial Fibrillary Acidic ProteinIBA 01/2005
1	Nucleic AcidsIBA 01/2005
1	salicylhydroxamic acid (SHAM)IBA 01/2005
1	Oxidopamine (6 Hydroxydopamine)IBA 04/2000

Therapy/Procedure

11	Transplantation 08/2008 - 03/2000
3	Therapeutics 01/2008 - 08/2000
1	Bioreactors (Bioreactor) 01/2006
1	Drug Therapy (Chemotherapy) 01/2005
1	Craniotomy 08/2000
1	Cannula 03/2000